Siva Thotapalli Siva Thotapalli My career challenge at Boehringer Ingelheim by Siva Thotapalli. Read it now!
Blue internal teat sealant now in dairy mastitis portfolio Blue internal teat sealant now in dairy mastitis portfolio Boehringer Ingelheim adds blue internal teat sealant to its dairy mastitis portfolio
Jean-Michel Boers Appointed to PhRMA Board of Directors Jean-Michel Boers Appointed to PhRMA Board of Directors Jean-Michel Boers Appointed to PhRMA Board of Directors
Partnering pet therapeutics Partnering pet therapeutics Learn more about our research focus and our most recent partnerships regarding pet therapeutics.
New Partnership to Develop Gene Therapy for Cystic Fibrosis New Partnership to Develop Gene Therapy for Cystic Fibrosis Boehringer Ingelheim steps into the field of gene therapy with experienced partners to jointly develop first gene therapy for cystic fibrosis
ATM-Ranking-2021 ATM-Ranking-2021 Boehringer Ingelheim climbs two places. New early-stage research projects for disease areas relevant to low-to-middle income countries not reflected.
bix_facilitates_global_partnerships bix_facilitates_global_partnerships BI X focuses on partnerships to speed up the development of digital healthcare solutions
Boehringer Ingelheim supports collaboration and knowledge sharing in the livestock industry Boehringer Ingelheim supports collaboration and knowledge sharing in the livestock industry Boehringer Ingelheim demonstrates its commitment to farm animal well-being by organising its 11th Expert Forum on Farm Animal Well-Being
digital_leader_award_2020 digital_leader_award_2020 Boehringer Ingelheim wins first place in the "STRATEGY" category of the Digital Leader Award
2020 European PRRS Research Award sponsorship 2020 European PRRS Research Award sponsorship 2020 European PRRS Research Award: Boehringer Ingelheim calls for submissions
Interview Dr Mehdi Shahidi Interview Dr Mehdi Shahidi Interview with Dr Mehdi Shahidi, Chief Medical Officer and Head of the Corporate Division Medicine at Boehringer Ingelheim
World Recycling Day: Closing the Loop World Recycling Day: Closing the Loop Transitioning the economy from a linear to a circular approach herculean task – but also an innovation that carries huge potential
Knowing the enemy: PRRS and PCVD Knowing the enemy: PRRS and PCVD The swine industry is constantly vigilant of viruses such as PRRS and PCV2 (PCVD). Learn about prevention, symptoms knowledge, and control measures to make a difference.
Pioneering for progress in generalized pustular psoriasis Pioneering for progress in generalized pustular psoriasis An event, bringing together 170 delegates from across the world to strive for excellence in care of GPP
Patient Organizations Patient Organizations Boehringer Ingelheim’s core principles and vision guide our work with patient organisations.
India: Many positive developments for the population India: Many positive developments for the population A conversation with interim country manager Sandip Agrawal about a young and growing country
Chronic kidney disease in cats Chronic kidney disease in cats Detect and manage chronic kidney disease and high blood pressure in cats
Boehringer Ingelheim 2022 half year results Boehringer Ingelheim 2022 half year results First half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline
Boehringer Ingelheim announces collaboration with MabGenesis Boehringer Ingelheim announces collaboration with MabGenesis Boehringer Ingelheim announces collaboration with MabGenesis to discover and develop novel monoclonal antibodies in canine
More health in vulnerable communities More health in vulnerable communities In an era of globalization and social connectivity, one-dimensional solutions often do not work anymore. Complex challenges need complex solutions.
A life in a day: the reality of living with lung cancer A life in a day: the reality of living with lung cancer Within the initiative “A life in a day”, Anna-Maria spent 24 hours in the shoes of a lung cancer patient to better understand the patient experience.
Uniting to stop rabies: a global and local endeavor Uniting to stop rabies: a global and local endeavor By collaborating together, we can stop rabies. Read how we are breaking down barriers through the power of partnerships to fight this deadly disease
Boehringer founding sponsor of CKM Health Initiative Boehringer founding sponsor of CKM Health Initiative Boehringer Ingelheim founding sponsor of AHA's Cardiovascular-Kidney-Metabolic Health Initiative
Research ruminant animal health well-being Research ruminant animal health well-being Boehringer Ingelheim supports young scientists and veterinarians dedicated to ruminant health research